February 17, 2025 - 03:14
A harm reduction advocate has raised concerns that President Trump's tariffs on Mexico and Canada, intended to combat the flow of fentanyl into the United States, may inadvertently worsen the ongoing opioid crisis. The advocate argues that these tariffs could lead to an increase in overdose rates as the cost of necessary medical supplies and harm reduction resources rises.
By imposing tariffs, the availability of life-saving naloxone, a medication used to reverse opioid overdoses, could be jeopardized. This could create barriers for organizations working on the front lines to provide essential services to those affected by addiction.
Additionally, the advocate emphasizes that the focus should be on comprehensive strategies that address the root causes of addiction, rather than punitive measures that may hinder access to critical resources. As the nation grapples with an escalating fentanyl crisis, the implications of these tariffs warrant careful consideration to avoid further harm to vulnerable communities.
